Prescription-UK

Prescription Medications
K List

  · Home     · FAQ     · About  



Prescription Medications



Health News Headline

Health Highlights: Sept. 12, 2013

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Camels May Be Linked to Deadly Respiratory Virus in People

Read entire article...
Kabergolin
Kainever
Kallmiren
Kalpress
Kalten
Kaltensif
Kaluril
Kapake
Kaplon
Kaptopril
Karbamazepin
Karbidopa-Levodopa
Karisoprodol
Karvea
Karvedilol
Keal
Kefexin
Keflex
Kefloridina
Kefol
Keforal
Kéforal
Keftab
Keftid
Kefurox
Kefzol
Kemadrin
Kemicetine
Ken-Jec
Kenoket
Kenolan
Kensodic
Kensoflex
Kenstatin
Kentadin
Kenzen
Keppra
Képpra
Kepra
Kerlon
Kerlone
Kessar
Kestine
Ketaman
Ketasma
Ketazolam
Ketazolame
Ketazolamum
Ketek
Ketiapin
Keto
Ketoconazol
Ketoconazole
Kétoconazole
Ketoderm
Ketoprofen
Kétoprofène
Ketoprofeno
Ketorol
Ketorolac
Ketorolaco
Ketotifen
Ketotifene
Kétotifène
Ketotifeno
Ketrel
Keval
Kevartil
Key-Pred
Kinetase
Kinxasen
Kitril
Klacid
Klaracid
Klaricid
Klaritromycin
Klindamycin
Klipal
Klomifen
Klonopin
Klopidogrel
Klopoxid
Klor Con
Klozapol
Konaderm
Kordaron
Korec
Kredex
Krestor
Kriadex
Kyliformon
Kytril


Some others: Flurbiprofen, Alloprim, Léflunomide, Norvir SEC, Fuxol, Generic Catapres, Mevacor, Pharmatovit, Velafaxine, Telithromycine, Busirone, Penbritin, ...


HealthCare News

FDA Bolsters Warnings About Class of Antibiotics

TUESDAY, July 26, 2016 (HealthDay News) -- The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including long-term nerve damage and ruptured tendons.

The agency also cautioned that these bacteria-fighting drugs -- including levofloxacin (Levaquin) and ciprofloxacin (Cipro) -- shouldn't be prescribed for sinusitis, chronic bronchitis or simple urinary tract infections unless no other treatments options exist.

"Fluoroquinolones have risks and benefits that should be considered very carefully," Dr. Edward Cox said in an FDA news release. He's director of the Office of Antimicrobial Products at the FDA's Center for Drug Evaluation and Research.

"It's important that both health care providers and patients are aware of both the risks and benefits of fluoroquinolones and make an informed decision about their use," Cox said.

Read entire article...

Other Names

  Browse Meds: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z



 

Copyright © 2015 Prescription-UK Terms of Service